SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED

This adverse event was reported 131 times

SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NITISINONE 1 0.0010
1 EQUINE THYMOCYTE IMMUNE GLOBULIN 1 0.0010
2 IRON DEXTRAN 1 0.0007
3 IBRITUMOMAB TIUXETAN 1 0.0007
4 NALDEMEDINE 1 0.0006
5 ENTRECTINIB 1 0.0006
6 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES 1 0.0006
7 IMIPENEM AND CILASTATIN SODIUM 1 0.0005
8 PRUCALOPRIDE 1 0.0004
9 AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL 1 0.0004
See all drugs enriched for association with SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED